Mevidence is a German medical AI company founded in 2025, providing “trusted AI assistants” for healthcare professionals, patients, and hospitals. Its core offering is not a general-purpose chatbot, but a set of tools built around medical guidelines, evidence-based resources, and in-house hospital documents: Knowledge Assistant, Patient Record Assistant, and Documentation Assistant. These are designed to reduce the burden of administrative search and clinical paperwork.
The product emphasizes fact-checking, expert-curated medical knowledge bases, and paragraph-level source citations. Knowledge Assistant can answer medical questions and show the underlying evidence, with support for jumping to the relevant sections of guidelines. Patient Record Assistant can generate structured summaries of patient records and answer patient-specific medical questions. Documentation Assistant helps generate clinical documents such as doctor’s letters, and can be adapted to specific templates and guidelines. The official website also claims that its answers reduce hallucinations by up to 80% compared with traditional RAG, but the evaluation method and sample details are not disclosed, so this claim should be treated with caution.
Pricing for the medical AI products is not publicly listed; the site only provides “request a demo/contact us” entry points, suggesting a hospital-level customized procurement model. The scraped English Pricing and Features pages contain many references to the “Virex” deployment platform, bandwidth, build minutes, and similar items, which are clearly unrelated to Mevidence’s medical AI business and should not be treated as a reliable basis for Mevidence’s actual pricing.
Mevidence’s strengths lie in compliance and deployment options. The official website states that it complies with GDPR and EU-MDR, uses European cloud infrastructure, and can also be deployed on hospital servers. It also supports integration with hospitals’ own knowledge sources, such as SOPs and publications, and mentions connectivity with hospital IT systems such as KIS, DMS, and AIM. However, open APIs, SDKs, interface standards, and implementation timelines are not disclosed.
Its advantages are a clear vertical focus on healthcare, strong emphasis on explainability and source traceability, and support for local deployment. It is suitable for European hospitals, specialist teams, and healthcare institutions with strict compliance requirements. The drawbacks are that the company is very new, with limited public customer cases, no transparent pricing, insufficient information on underlying models and clinical validation, and unclear Chinese-language support. It is not suitable as a plug-and-play consumer tool for individuals.
Accessibility, payment, and procurement feasibility from mainland China are unknown. Given its strong orientation toward European regulations and German-language medical content, deployment in Chinese hospitals would still require consideration of network access, cross-border data transfer, medical compliance, and adaptation to local knowledge bases. Comparable alternatives include Nuance DAX, Abridge, Ambience Healthcare, OpenEvidence, as well as Chinese solutions such as iFLYTEK Healthcare, Baidu Lingyi, and Yidu Tech.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mevidence.com official site.
mevidence.com is an Germany AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach mevidence.com directly.